Teradyne rose more than 8% before the market opened, and its Q2 performance guidance exceeded expectations.

stock analyst • • US stock market

.app-kaihu-qr{text-align: center;padding: 20px 0;}.app-kaihu-qr span{font-size: 18px; line-height: 31px;display: block;}.app-kaihu-qr img{width: 170px;height: 170px;display: block;margin: 0 auto;margin-top: 10px;}The stock market is picking up, open an account first to buy stocks at the bottom! Smart fixed investment, conditional orders, individual stock radar…given to you>> .appendQr_wrap{border:1px solid #E6E6E6;padding:8px;} .appendQr_normal{float:left;} .appendQr_normal img{width:74px;} .appendQr_normal_txt{ float:left;font-size:20px;line-height:74px;padding-left:20px;color:#333;} Massive information and accurate interpretation, all in Sina Finance APP Editor-in-Chief: Guo Mingyu

Gelonghui April 25 | Semiconductor equipment manufacturer Teradyne (TER.US) rose 8.58% before the market opened, reporting at $109.34.
According to the news, the company’s net income for the quarter ended March 31 was US$0.33, down from US$617.5 million in the same period last year to US$599.8 million.
The company expects second-quarter non-GAAP earnings per share of $0.64 to $0.84 on revenue of $665 million to $725 million.
It was higher than market expectations of earnings per share of US$0.60 and revenue of US$644.8 million.

Like (0)
stock analyststock analyst
Previous April 25, 2024 5:03 pm
Next April 25, 2024 5:04 pm

Related posts

  • Guangxin Shares (603599.SH): Net profit in the first quarter was 225 million yuan, a year-on-year decrease of 56.80%

    Gelonghui April 25 | Guangxin Co., Ltd. (603599.SH) released its first quarter report for 2024. During the reporting period, the company’s operating income was 1.215 billion yuan, a year-on-year decrease of 36.89%; the net profit attributable to shareholders of the listed company was 225 million yuan, A year-on-year decrease of 56.80%; the net profit attributable to shareholders of listed companies excluding non-recurring gains and losses was 215 million yuan, a year-on-year decrease of 55.06%; basic earnings per share was 0.25 yuan/share.

    US stock market April 25, 2024

  • just! Lei Jun: The past 28 days have been like a dream, Xiaomi Motors will launch the international market in 3 years

    Special Topic: 2024 Zhongguancun Forum Annual Meeting Beijing Business Daily On April 25, the 2024 Zhongguancun Forum Annual Meeting opened. Lei Jun, founder, chairman and CEO of Xiaomi Group, said in an on-site interview that I was a little excited today because Xiaomi Auto held a press conference in the morning and announced the entire process of 28 days of ups and downs and trembling. Lei Jun said that it is the intertwining of two strong emotions. The sales situation is very good, so good that you can\’t believe it, because you are afraid… I said something, the past 28 days were like a dream, I admit it But I can\’t believe it. Is this true? Also, when everyone looks at you with a 10,000-fold magnifying glass, all the questions they ask you become questions. So we are very anxious every day. We even \”invented\” a mode to answer all the questions from netizens that day every night, no matter how late it is. We face all doubts, rumors, and questions head-on. Lei Jun also said, I feel like I…

    US stock market April 25, 2024

  • Hedge fund Rokos executive: Fed unlikely to cut interest rates this year

    Richard Tang, global head of markets at hedge fund Rokos Capital Management, believes the Fed is unlikely to loosen monetary policy this year.

    US stock market 1 day ago

  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market April 25, 2024

  • Continued yen weakness comes as BOJ scales back routine bond purchases

    The Bank of Japan seeks to reduce its presence in the bond market, proposing to buy government bonds in regular operations on Monday, down from April 24.

    US stock market 4 days ago

  • Havells gathers speed to hit all-time high; analysts divided over its prospects

    Shares of Havells India Ltd surged on Thursday after the company reported its Q4 financial results. The stock has hit a fresh high at ₹1,706.85 and traded at ₹1,669.20 on the NSE, up 0.31 per cent as of 1.03 pm. .

    US stock market May 3, 2024